Note:This document is a translation of a part of the original Japanese version and provided for reference purposes only. In the event of any discrepancy between
the Japanese original and this English translation, the Japanese original shall prevail.

Consolidated Financial Results
for the Year Ended March 31, 2022
[Japanese GAAP]May 13, 2022
Company name: SUNCORPORATION
Stock exchange listing: Tokyo
Code number: 6736
URL: https://www.sun-denshi.co.jp
Representative: Ryusuke Utsumi
President and Representative Director
Contact: Yoshimi Kimura
Representative and Executive managing director
Phone: 052-756-5981
Scheduled date of Annual General Meeting of Shareholders: June 23, 2022
Scheduled date of commencing dividend payments: June 24, 2022
Scheduled date of filing annual securities report: June 24, 2022
Availability of supplementary briefing material on annual financial results: Yes
Schedule of annual financial results briefing session: Yes(Amounts of less than one million yen are rounded down)
1. Consolidated Financial Results for the Fiscal Year Ended March 31, 2022 (April 01, 2021 to March 31, 2022)(1) Consolidated Operating Results(% indicates changes from the previous corresponding period.)
Profit attributable toNet sales
Operating profit
Ordinary profit
owners of parent
Million yen%
Million yen%
Million yen%
Million yen%
Fiscal year ended
March 31, 2022
37,205
39.5
1,360
98.0
9,673
998.0
2,818
March 31, 2021
26,662
1.7
687
881
47(Note) Comprehensive income:Fiscal year ended March 31, 2022:¥
8,375 million [-%]
Fiscal year ended March 31, 2021:¥(435) million [-%]
Basic earnings per Diluted earnings per Rate of return onshareshareequity

Ordinary profit tototal assets ratio

Yen
Yen%
Fiscal year ended
March 31, 2022
117.77108.47
12.5
March 31, 2021
2.08
1.98
0.3
(Reference) Equity in earnings (losses) of affiliated companies: Fiscal year ended March 31, 2022:
Fiscal year ended March 31, 2021:

Operating profit tonet sales ratio

%%

14.7
1.9
¥
¥

3.7
2.6
millionmillion(2) Consolidated Financial Position
Total assets
As ofMarch 31, 2022
March 31, 2021
(Reference) Equity:

Net assets

Capital adequacy ratio

Net assets per share

Million yen

Million yen%

Yen

82,08849,78527,04020,82029.7
28.9

1,018.23
601.92As of March 31, 2022:
As of March 31, 2021:¥¥million
14,391 million(3) Consolidated Cash Flows
Cash flows fromoperating activities
Fiscal year ended
March 31, 2022
March 31, 2021

Cash flows frominvesting activities

Cash flows fromfinancing activities

Cash and cash
equivalents at the endof period

Million yen

Million yen

Million yen

Million yen

3,632
6,110

4,020
(910)

(3,036)
3,598

27,438
21,113

2. Dividends
Annual dividends
1st2nd3rdquarter-end quarter-end quarter-endYear-end

Total

Total
dividends

Payoutratio(consolidated)

Dividends
to netassets(consolidated)

Fiscal year ended

YenYenYenYen

Yen

Million yen%%March 31, 2021

-

0 00

-

10 00

10 00

239

481.4

1.7

March 31, 2022

-

20 00

-

20 00

40 00

957

34.0

0.5

-----

Fiscal year ending
March 31, 2023-

(Forecast)(Note) The dividend forecast for the fiscal year ending March 31, 2022 has not been determined at this time.

3. Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023 (April 01, 2022 to March 31, 2023)
The forecast for the consolidated financial results of the fiscal year ending March 31, 2022 has no yet been determined because it isdifficult to reasonably calculate the change in the fair value and their impact on Sun Corporation’s financial results due to the priceadjustment clause, certain restricted shares, and the derivative warrant liabilities held by TWC Tech Holdings II Corp. based on themerger agreement when Sun Corporation’s Israeli consolidated subsidiary, Cellebrite DI Ltd became listed on the NASDAQ GlobalMarket.
We will promptly announce the consolidated earnings forecast as soon as it becomes available.
* Notes:(1) Changes in significant subsidiaries during the period under review (changes in specified subsidiaries resulting in changes inscope of consolidation): No(2) Changes in accounting policies, changes in accounting estimates and retrospective restatement
1) Changes in accounting policies due to the revision of accounting standards: Yes
2) Changes in accounting policies other than 1) above: No
3) Changes in accounting estimates: No4) Retrospective restatement: No(3) Total number of issued shares (common shares)
1) Total number of issued shares at the end of the period (including treasury shares):
March 31, 2022:
23,992,328 shares
March 31, 2021:
23,961,128 shares2) Total number of treasury shares at the end of the period:
March 31, 2022:
51,262 shares
March 31, 2021:
51,234 shares
3) Average number of shares during the period:
Fiscal Year ended March 31, 2022:
Fiscal Year ended March 31, 2021:

23,933,693 shares
22,808,209 shares

(Reference) Summary of Non-consolidated Financial Results
1. Non-consolidated Financial Results for the Fiscal Year Ended March 31, 2022 (April 01, 2021 to March 31, 2022)(1) Non-consolidated Operating Results(% indicates changes from the previous corresponding period.)
Net sales
Fiscal year ended
March 31, 2022
March 31, 2021

Operating profit

Ordinary profit

Net income

Million yen%

Million yen%

Million yen%

Million yen%

8,046
5,484

46.7
(21.7)

112(67)

-

8,579
(52)

-

23,998(83)-Basic earnings per share Diluted earnings per shareYenYen
Fiscal year ended
March 31, 2022
1,002.69
1,000.79March 31, 2021
(3.66)※Diluted earnings per share for the year ended March 31, 2021 is not presented even though the Company has issued potential shares,
because basic earnings per share was net loss.

(2) Non-consolidated Financial Position
Total assets
As ofMarch 31, 2022
March 31, 2021
(Reference) Equity:

Net assets

Million yen

47,076
13,465
As of March 31, 2022:
As of March 31, 2021:

Capital adequacy ratio

Million yen¥¥

32,0805,655
32,032 million
5,609 million

Net assets per share%Yen

68.0
41.7

1,337.97
234.60※This quarterly financial report is not subject to the quarterly review by a certified public accountant or an auditing firm.
※An explanation on the appropriate use of earnings forecasts and other special notes
The forecast of consolidated results for the year ending 31 March 2023 has not been determined it is difficult to reasonably estimate theimpact on the results of changes in the fair value of the price adjustment clauses, certain restricted shares and derivative warrant liabilities
recognized in Sun Corporation’s Israeli consolidated subsidiary, Cellebrite DI Ltd.